Pre-Congress Live Webinar:10th Annual Proteins & Antibodies Congress

PRE CONGRESS WEBINAR RECORDING AVAILABLE TO DOWNLOAD

The protein & antibody biotherapeutics market represents a growing area of pharmaceutical research that is currently experiencing a lot of attention: advancements in developing therapeutics proteins and antibodies as well as utilising nanobodies for therapeutic research are supporting the expansion of the industry hugely. Oxford Global’s free webinar recording offers you a unique chance to listen to industry experts discuss the recent improvements towards achieving designed recombinant therapeutic neurotoxins and utilising nanobodies for immunotherapy.

Our Webinar Presenters:
Matthew Beard, Senior Principal Scientist, Ipsen Bioinnovation:
Advances Towards Designed Recombinant Therapeutic Neurotoxins
 ▪ Current therapeutic neurotoxins are natural proteins purified from native sources
 ▪ Recombinant technology offers ways to improve manufacture and design new therapeutic neurotoxins tailored to patient’s needs

Antonin De Fougerolles, Chief Scientific Officer, Ablynx:
Biotherapeutics: Utilising Nanobodies For Immunotherapy
 ▪ Advances in multivalent and multi-specific Nanobodies for immune-oncology
 ▪ Case study: Using multi-specific Nanobodies to generate the next generation T cell recruiter platform
 ▪ Case study: Improving agonist activity using a multivalent GITR Nanobody

Download for free here >>

If you would like further information regarding this webinar, please contact Danielle Dalby today on +44 (0) 1865 248455 or email d.dalby@oxfordglobal.co.uk